Danaher Co. (NYSE:DHR) Shares Sold by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA decreased its stake in Danaher Co. (NYSE:DHR) by 6.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,709 shares of the conglomerate’s stock after selling 792 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Danaher were worth $2,688,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of DHR. Coronation Fund Managers Ltd. lifted its stake in shares of Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after buying an additional 1,470 shares in the last quarter. Oppenheimer & Co. Inc. raised its stake in shares of Danaher by 4.0% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 25,004 shares of the conglomerate’s stock valued at $6,247,000 after acquiring an additional 957 shares during the period. Parallel Advisors LLC raised its stake in shares of Danaher by 3.4% in the 2nd quarter. Parallel Advisors LLC now owns 13,524 shares of the conglomerate’s stock valued at $3,379,000 after acquiring an additional 445 shares during the period. Thoroughbred Financial Services LLC grew its holdings in shares of Danaher by 124.1% in the second quarter. Thoroughbred Financial Services LLC now owns 1,956 shares of the conglomerate’s stock valued at $488,000 after purchasing an additional 1,083 shares in the last quarter. Finally, Wealthspire Advisors LLC grew its holdings in shares of Danaher by 3.5% in the second quarter. Wealthspire Advisors LLC now owns 4,823 shares of the conglomerate’s stock valued at $1,205,000 after purchasing an additional 165 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

NYSE DHR traded up $4.44 on Monday, reaching $239.51. The company’s stock had a trading volume of 1,164,517 shares, compared to its average volume of 2,607,598. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $172.99 billion, a PE ratio of 45.71, a PEG ratio of 4.32 and a beta of 0.83. The firm’s 50 day moving average is $235.67 and its two-hundred day moving average is $253.73.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the company posted $2.02 earnings per share. The firm’s revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s payout ratio is 20.61%.

Wall Street Analyst Weigh In

Several research firms have commented on DHR. Barclays lowered their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. UBS Group reduced their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. TD Cowen upped their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada reduced their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Stephens restated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.